Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > PRIVATE PLACEMENT EXTENSION

<< Previous

Bullboard Posts

Next >>

Comment by 90guppyon Nov 23, 2020 11:04am

57 Views

Post# 31952181

RE:RE:RE:RE:RE:PRIVATE PLACEMENT EXTENSION

non-brokered, that explains it all

Padina wrote: If DG is as wise as i think he's, he shuold know that he is the face of the company. Whatever decision they take it is on his name. And as far as reputation goes, DG doesnt seems to have any left.
If insiders had filled up the PP ASAP there would have been no available slot for outsiders to fill.
Insiders claiming they av the money yet they can get d PP closed- it dosent add up

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?